NAS:RXRX (USA)
Â
Class A
$
7.24
+0.25 (+3.58%)
11:08 PM EST
New Key Statistics Module, Z-Score and F-Score
NAS:RXRX Key Ratios
| Market Cap $ M | 2,731.15 |
| Enterprise Value $ M | 2,020.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.95 |
| Price/Sales | 28.28 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 64.00 |
| EPS (TTM) $ | -1.55 |
| Beneish M-Score | -3.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.29 |
| EV-to-EBITDA | -5.76 |
| PEG | -- |
| Shares Outstanding M | 390.72 |
| Net Margin (%) | -584.75 |
| Operating Margin % | -610.16 |
| Pre-tax Margin (%) | -592.79 |
| Quick Ratio | 4.35 |
| Current Ratio | 4.35 |
| ROA % (ttm) | -56.47 |
| ROE % (ttm) | -78.32 |
| ROIC % (ttm) | -130.11 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.95 |
RXRX Number of Guru Trades
RXRX Volume of Guru Trades
Gurus Latest Trades with NAS:RXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RXRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Recursion Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RXRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers